The Journal of Phytopharmacology, 2018;7(5):412-418 DOI:10.31254/phyto.2018.7502
Toxicity Evaluation of a Traditional Polyherbal Unani Formulation Jawarish Shahi in Rats
Mohd Urooj1 , Mohammad Ahmed Khan1 , G. Thejaswini1 , Munawwar Husain Kazmi1 , Gulam Mohammed Husain1
1. Central Research Institute of Unani Medicine, Hyderabad, India
*Author to whom correspondence should be addressed.
Received: 7th August, 2018 / Accepted: 11th October, 2018
Jawarish Shahi (JS) is a compound polyherbal Unani pharmacopoeial formulation indicated for Khafqan (Palpitation), Nafkh-e-Shikam (Flatulence) and Waswas (Insanity; false perception and hallucinations). Jawarish Shahi contains herbs like Halela (Terminalia chebula), Amla (Emblica officinalis), Kishneez (Coriandrum sativum), Elaichi Khurd, (Elettaria cardamomum), and Bed Mushk (Salix caprea). The present study was carried out as per OECD 408 guidance to evaluate 90 days repeated oral dose toxicity in male and female Sprague Dawley rats. The study was performed at dose levels 1028 and 2000 mg/kg bw. No adverse effects were reported with respect to body weight, feed intake, behavior and clinical signs indicative of systemic toxicity. The expected growth pattern was observed in body weight and feed intake as compared to control group at both dose levels in male and female rats. There were few significant alterations with respect to hematology, and clinical biochemistry, however the results were within normal range thus considered toxicologically insignificant. The microscopic examination of different organ/tissue showed that no histopathological changes were observed. The findings of the study showed that No Observed Adverse Effect Level (NOAEL) for JS is greater than 2000 mg/kg body weight.
Jawarish Shahi, Toxicity, Rat, Unani.
HOW TO CITE THIS ARTICLE
Urooj M, Khan MA, Thejaswini G, Kazmi MH, Husain GM. Toxicity Evaluation of a Traditional Polyherbal Unani Formulation Jawarish Shahi in Rats. J Phytopharmacol 2018; 7(5):412-418.
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2018 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.